Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
403 Correlative analysis of blood and biopsy samples from a clinical trial of Hsp90 inhibition in combination with pembrolizumab reveals increased intratumoral myeloid cell accumulation after treatment
Compose a Response to This Article
Other responses
No responses have been published for this article.